Epstein-Barr virus and human cells: transforming and cell-killing infections
Mizuno, F.
Hokkaido Journal of Medical Science 53(6): 489-495
1978
ISSN/ISBN: 0367-6102 PMID: 230999 Document Number: 138154
Document emailed within 1 workday
Related Documents
Ohtsubo, H.; Arima, N.; Matsushita, K.; Hidaka, S.; Fujiwara, H.; Arimura, K.; Kukita, T.; Fukumori, J.; Matsumoto, T.; Eizuru, Y.; Tanaka, H. 1997: Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia Experimental Hematology 25(12): 1246-1252Plotnicky, H.; Touraine, J.L. 1993: Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants Clinical and Experimental Immunology 94(3): 494-499
Hamilton-Dutoit, S.J.; Pallesen, G. 1992: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas American Journal of Pathology 140(6): 1315-1325
Hampar, B.; Martos, L.M.; Walker, J.L. 1971: Epstein-Barr virus in human lymphoblastoid cells: enhancing the percentage of virus-positive cells by cocultivation with African green monkey (Vero) cells Journal of the National Cancer Institute 47(3): 535-537
Okuno, T. 1998: Laboratory diagnosis of viral infections. 7. Opportunistic infection by herpesviruses (human cytomegalovirus, Epstein-Barr virus, and human herpesvirus 8) Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 108: 98-104
Kinoshita, T. 1990: Studies on transforming functions of Epstein-Barr virus-specific proteins Hokkaido Journal of Medical Science 65(4): 362-375
Klein, E.; Ernberg, I.; Masucci, M.G.; Szigeti, R.; Wu, Y.T.; Masucci, G.; Svedmyr, E. 1981: T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis Cancer Research 41(11 Part 1): 4210-4215
Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Kessler, D.J.; Heilman, C.A.; Cossman, J.; Maguire, R.T.; Thorgeirsson, S.S. 1987: Transformation of Epstein-Barr virus immortalized human B-cells by chemical carcinogens Cancer Research 47(2): 527-531
Wolf, J.; Pawlita, M.; Bullerdiek, J.; zur Hausen, H. 1990: Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression Cancer Research 50(10): 3095-3100
Glaser, R.; Lenoir, G.; Ferrone, S.; Pellegrino, M.A.; de-Thé, G. 1977: Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus Cancer Research 37(7 Part 1): 2291-2296
Tosato, G.; Marti, G.E.; Yarchoan, R.; Heilman, C.A.; Wang, F.; Pike, S.E.; Korsmeyer, S.J.; Siminovitch, K. 1986: Epstein-Barr virus immortalization of normal cells of B cell lineage with nonproductive, rearranged immunoglobulin genes Journal of Immunology 137(6): 2037-2042
Boyle, T.J.; Tamburini, M.; Berend, K.R.; Kizilbash, A.M.; Borowitz, M.J.; Lyerly, H.K. 1992: Human B-cell lymphoma in severe combined immunodeficient mice after active infection with Epstein-Barr virus Surgery 112(2): 378-386
Skibiński, G.; James, K. 1989: Reactivation of antibody genes in Epstein-Barr virus transformed human B cell lines. A preliminary report Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 295-300
Yamamoto, N.; Mitsuma, T.; Vogt, A. 1982: Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines Journal of the National Cancer Institute 68(3): 385-390
Razonable, R.R.; Paya, C.V. 2003: Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections Herpes: the Journal of the Ihmf 10(3): 60-65
Yang, T.-t.; Wang, Y.; Liu, X.; Li, X.; Pang, Z.-c.; Luo, B. 2009: Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma Bing du Xue Bao 25(1): 29-34
Monrozies, M.; Enjalbert, L.; Didier, J.; Icart, J.; Boucays, A. 1980: Epstein-Barr virus infections in pregnancy. the serological profile of active infections in pregnant women. their possible relationship with perinatal mortality Journal de Gynecologie Obstetrique et Biologie de la Reproduction 9(3): 293-297
Rymo, L. 1983: Transfer of the Epstein-Barr virus genes coding for small RNAs to human lymphoid cells with a vector carrying a dominant selectable marker EMBO Journal 2(6): 839-844